ID   COH-DHL1
AC   CVCL_C1GL
SY   City Of Hope-Double Hit Lymphoma 1
DR   Wikidata; Q114310995
RX   PubMed=35687491;
CC   Doubling time: 47.8 hours (PubMed=35687491).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=35687491).
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Gly12Asp (c.35G>A); Zygosity=Heterozygous (PubMed=35687491).
CC   Omics: Transcriptome analysis by RNAseq.
ST   Source(s): PubMed=35687491
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=35687491; DOI=10.1182/bloodadvances.2021006709; PMCID=PMC9631616;
RA   Zhang J.-B., Wang T.-T., Shetty K., Alkan S., Xu S.-L., Gong Q.,
RA   Liu X.-X., Li Y.-P., Hu Z.-S., Huang W.-D., Wendel H.-G., Herrera A.F.,
RA   Pillai R.K., Song J.Y., Chan W.-C.;
RT   "Genetic characterization and drug sensitivity study of newly derived
RT   HGBL double/triple-hit lymphoma cell lines.";
RL   Blood Adv. 6:5067-5071(2022).
//